Healthcare -
Biotechnology - NASDAQ - US
$ 0.6439
-8 %
$ 22.8 M
Market Cap
-5.37
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
32.59%
EBIT
Estimate
57.72%
Net Income
Estimate
30.30%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Equillium, Inc.
EQ has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart EQ
EBIT FORECAST
EBIT Forecast Chart EQ
NET INCOME FORECAST
Net Income Chart EQ